Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Tihomir Tomašić

PhD Tihomir Tomašić
no.: 28334 source: ARIS

researcher – active in research organisation
tihomir.tomasicat signffa.uni-lj.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Croatian
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
  • German
  • Reading: Functional
  • Writing: Basic
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
B200  Biomedical sciences  Cytology, oncology, cancerology 
B230  Biomedical sciences  Microbiology, bacteriology, virology, mycology 
Keywords
drug design; inhibitor; molecular modelling; DNA gyrase; Hsp90; antibacterial activity; anticancer activity
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
1,291.43
A''
207.44
A'
748.78
A1/2
952.94
CI10
1,936
CImax
208
h10
24
A1
4.72
A3
2.18
Data for the last 5 years (citations for the last 10 years) on September 30, 2023; A3 for period 2017-2021 (update for tender in 2022: YES)
Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 111  2,260  1,835  16.53 
Scopus 113  2,492  2,025  17.92 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Jaka Dernovšek  Bologna doctoral studies  10/1/2020 - 9/30/2024  54784 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2006 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2011 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  11/1/2006  Professor  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-4496  Adjuvansi naslednje generacije za mukozna cepiva (Slovene)   2022 - 2023  PhD Žiga Jakopin  1,035 
2. J7-4635  MitoCan - Predklinični razvoj novih zaviralcev mitohondrijskih ionskih kanalov za zdravljenje raka (Slovene)   2022 - 2023  PhD Lucija Peterlin Mašič  5,812 
3. J1-4400  Vrednotenje prehodnih stanj proteinov (Slovene)   2022 - 2023  PhD Simona Golič Grdadolnik  3,095 
4. J1-3031  Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance   2021 - 2023  PhD Nace Zidar  989 
5. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance   2021 - 2023  PhD Lucija Peterlin Mašič  914 
6. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2020 - 2023  PhD Žiga Jakopin  1,940 
7. J1-2483  Radiopharmaceuticals with antagonistic activity on CCK2R   2020 - 2023  PhD Marko Anderluh  999 
8. J1-2485  The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs   2020 - 2023  PhD Izidor Sosič  893 
9. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   2019 - 2023  PhD Tihomir Tomašić  1,820 
10. N1-0098  Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity   2019 - 2022  PhD Lucija Peterlin Mašič  846 
11. J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants   2018 - 2022  PhD Žiga Jakopin  2,702 
12. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   2018 - 2021  PhD Lucija Peterlin Mašič  2,111 
13. J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi   2017 - 2020  PhD Metka Filipič  3,616 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2022 - 2023  PhD Stanislav Gobec  5,115 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2015 - 2021  PhD Stanislav Gobec  5,765 
3. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2009 - 2014  PhD Danijel Kikelj  5,649 
4. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2007 - 2008  PhD Danijel Kikelj  5,845 
International projects
no. Code Title Period Head
1. COST-CA15135  Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)   4/18/2016 - 4/17/2020     
2. COST-CM1307  Targeted chemotherapy towards diseases caused by endoparasites   3/12/2014 - 3/11/2018     
Confirmation required
Views history
Favourite